Could I double my money if I buy at this Darktrace share price?

The Darktrace share price has been volatile since its IPO. Yet, analysts expect the stock to double. Should I buy the shares for my own portfolio?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

The Darktrace (LSE: DARK) share price has been volatile since its initial public offering in April last year. The shares listed at 250p, rocketed up to 1,000p in September, and have fallen back to 373p as I write today.

However, City analysts have a consensus target price of 797p for Darktrace stock. That would be a 111% return, or a more than double my initial investment if I bought the shares today. Analysts aren’t always right, though. So, it’s important for me to form my own view before I buy any shares. Let’s take a closer look at the company.

The investment case

Darktrace operates in the cybersecurity industry. It’s area that I think will be in increasing demand as the world becomes more digital. This should, in theory, benefit Darktrace in the years ahead. Indeed, according to Fortune Business Insights, the cybersecurity market is expected to grow from $166bn in 2021 to $366bn in 2028.

On its website, Darktrace says it’s a world leader in autonomous artificial intelligence (AI) for cybersecurity. The signs look promising, too. For example, there are currently 6,531 customers using its cybersecurity products according to the recent trading update for the six months to 31 December (HY22). Customer numbers actually increased by 39.6% over the same period in 2020. Furthermore, Darktrace says its AI solutions are able to interrupt cyber attacks in seconds.

The recent trading update also showed strong growth in the business. Revenue increased 50% in the first six months of HY22. Guidance was also raised for its full-year revenue expectations to 30 June, and margins should increase, too. I can see why City analysts are expecting the share price to more than double if this growth continues.

Should I buy at this Darktrace share price?

However, Darktrace is still loss-making, which does make the investment riskier. The company isn’t expected to turn a profit for at least the next three years either. Based on a forward price-to-sales ratio though, the shares are valued on a multiple of seven. I consider this quite high. But if revenue continues to grow by double-digits, and the company maintains a 90% gross margin, then it isn’t unreasonable, in my view.  

My biggest issue today, though, is with the product. In fact, some customers have likened Darktrace’s products to “snake oil” due to the disconnect between the marketing of what its AI-driven solutions offer, and what it actually provides. This does make me question whether Darktrace’s AI is as good as it says it is. And although the recent trading was positive, it could be down to excellent marketing, rather than a world-leading cybersecurity product.

On this last point, Darktrace did say that churn had significantly improved over the half-year to 31 December. This does suggest that customers are sticking around and finding value in its products.

Nevertheless, there are too many risks on the product side for me to invest today, even though analysts expect the share price to double. Therefore, I think there’ll be considerable share price volatility ahead. Until Darktrace addresses the concerns over its product offering, I won’t be investing.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Dan Appleby has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »